HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.

AuthorsG Jäger, P Neumeister, F Quehenberger, S Wöhrer, W Linkesch, M Raderer
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 17 Issue 11 Pg. 1722-3 (Nov 2006) ISSN: 0923-7534 [Print] England
PMID16766585 (Publication Type: Clinical Trial, Phase III, Letter, Multicenter Study)
Chemical References
  • Antineoplastic Agents
  • Cladribine
Topics
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Cladribine (administration & dosage, therapeutic use)
  • Follow-Up Studies
  • Humans
  • Lymphoma, B-Cell (drug therapy)
  • Lymphoma, B-Cell, Marginal Zone (drug therapy)
  • Remission Induction
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: